Literature DB >> 21461068

Probiotic Fermented Milk Containing Dietary Fiber Has Additive Effects in IBS with Constipation Compared to Plain Probiotic Fermented Milk.

Sung Chul Choi1, Beom Jin Kim, Poong-Lyul Rhee, Dong Kyung Chang, Hee Jung Son, Jae J Kim, Jong Chul Rhee, Soon Im Kim, Young Sil Han, Ki Hyeon Sim, Seok Nam Park.   

Abstract

BACKGROUND/AIMS: Although controversial, probiotics and dietary fiber are commonly used for patients with irritable bowel syndrome (IBS). We evaluated the effects of multistrain probiotics on the symptoms of IBS to determine whether the addition of dietary fi ber had an additive effect on constipation-predominant IBS.
METHODS: A total of 142 participants who met the Rome III criteria were recruited and randomized into a control group or a test group. Participants in the control group received multistrain probiotic fermented milk with Streptococcus thermophilus, Lactobacillus acidophilus and Bifidobacterium infantis; the participants in the test group received the same probiotic fermented milk mixed with dietary fi ber such as sea tangle extracts, radish extracts and glasswort extracts. The patients were treated for four weeks.
RESULTS: Most of the symptoms of IBS, with the exception of fl atulence, stool consistency, and frequency of defecation, signifi cantly improved in both groups. In the analysis of IBS subtypes, especially constipation-predominant IBS, the frequency and duration of defecation and straining at stool were improved more in the test group than in the control group.
CONCLUSIONS: Dietary fiber had additive benefits for the symptoms of constipation, especially in constipation-predominant IBS.

Entities:  

Keywords:  Constipation; Dietary fiber; Irritable bowel syndrome; Probiotic fermented milk

Year:  2011        PMID: 21461068      PMCID: PMC3065089          DOI: 10.5009/gnl.2011.5.1.22

Source DB:  PubMed          Journal:  Gut Liver        ISSN: 1976-2283            Impact factor:   4.519


  29 in total

Review 1.  AGA technical review on irritable bowel syndrome.

Authors:  Douglas A Drossman; Michael Camilleri; Emeran A Mayer; William E Whitehead
Journal:  Gastroenterology       Date:  2002-12       Impact factor: 22.682

2.  Activation of the mucosal immune system in irritable bowel syndrome.

Authors:  Vinton S Chadwick; Wangxue Chen; Dairu Shu; Barbara Paulus; Peter Bethwaite; Andy Tie; Ian Wilson
Journal:  Gastroenterology       Date:  2002-06       Impact factor: 22.682

3.  Single-blind follow-up study on the effectiveness of a symbiotic preparation in irritable bowel syndrome.

Authors:  J Tsuchiya; R Barreto; R Okura; S Kawakita; E Fesce; F Marotta
Journal:  Chin J Dig Dis       Date:  2004

4.  Probiotic impact on microbial flora, inflammation and tumour development in IL-10 knockout mice.

Authors:  L O'Mahony; M Feeney; S O'Halloran; L Murphy; B Kiely; J Fitzgibbon; G Lee; G O'Sullivan; F Shanahan; J K Collins
Journal:  Aliment Pharmacol Ther       Date:  2001-08       Impact factor: 8.171

5.  Bacterial supplementation in the irritable bowel syndrome. A randomised double-blind placebo-controlled crossover study.

Authors:  M A O'Sullivan; C A O'Morain
Journal:  Dig Liver Dis       Date:  2000-05       Impact factor: 4.088

6.  Effect of Lactobacillus plantarum 299v on colonic fermentation and symptoms of irritable bowel syndrome.

Authors:  S Sen; M M Mullan; T J Parker; J T Woolner; S A Tarry; J O Hunter
Journal:  Dig Dis Sci       Date:  2002-11       Impact factor: 3.199

Review 7.  Management of the irritable bowel syndrome.

Authors:  M Camilleri
Journal:  Gastroenterology       Date:  2001-02       Impact factor: 22.682

8.  DNA from probiotic bacteria modulates murine and human epithelial and immune function.

Authors:  Humberto Jijon; Jody Backer; Hugo Diaz; Helen Yeung; David Thiel; Conor McKaigney; Claudio De Simone; Karen Madsen
Journal:  Gastroenterology       Date:  2004-05       Impact factor: 22.682

Review 9.  Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome.

Authors:  M Camilleri; R C Heading; W G Thompson
Journal:  Aliment Pharmacol Ther       Date:  2002-08       Impact factor: 8.171

Review 10.  Systematic review: the role of different types of fibre in the treatment of irritable bowel syndrome.

Authors:  C J Bijkerk; J W M Muris; J A Knottnerus; A W Hoes; N J de Wit
Journal:  Aliment Pharmacol Ther       Date:  2004-02-01       Impact factor: 8.171

View more
  4 in total

1.  Effect of composite yogurt enriched with acacia fiber and Bifidobacterium lactis.

Authors:  Yang Won Min; Sang Un Park; Yeon Sil Jang; Young-Ho Kim; Poong-Lyul Rhee; Seo Hyun Ko; Nami Joo; Sun Im Kim; Cheol-Hyun Kim; Dong Kyung Chang
Journal:  World J Gastroenterol       Date:  2012-09-07       Impact factor: 5.742

Review 2.  Unraveling the ties between irritable bowel syndrome and intestinal microbiota.

Authors:  Sung Noh Hong; Poong-Lyul Rhee
Journal:  World J Gastroenterol       Date:  2014-03-14       Impact factor: 5.742

3.  Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool.

Authors:  Kok-Ann Gwee; Uday C Ghoshal; Sutep Gonlachanvit; Andrew Seng Boon Chua; Seung-Jae Myung; Shaman Rajindrajith; Tanisa Patcharatrakul; Myung-Gyu Choi; Justin C Y Wu; Min-Hu Chen; Xiao-Rong Gong; Ching-Liang Lu; Chien-Lin Chen; Nitesh Pratap; Philip Abraham; Xiao-Hua Hou; Meiyun Ke; Jane D Ricaforte-Campos; Ari Fahrial Syam; Murdani Abdullah
Journal:  J Neurogastroenterol Motil       Date:  2013-04-16       Impact factor: 4.924

4.  Association between Altered Blood Parameters and Gut Microbiota after Synbiotic Intake in Healthy, Elderly Korean Women.

Authors:  Song Hee Lee; Hee Sang You; Hee-Gyoo Kang; Sang Sun Kang; Sung Hee Hyun
Journal:  Nutrients       Date:  2020-10-12       Impact factor: 5.717

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.